Engraftable human neural stem cells respond to development cues, replace neurons, and express foreign genes
JD Flax, S Aurora, C Yang, C Simonin, AM Wills… - Nature …, 1998 - nature.com
Stable clones of neural stem cells (NSCs) have been isolated from the human fetal
telencephalon. These self-renewing clones give rise to all fundamental neural lineages in …
telencephalon. These self-renewing clones give rise to all fundamental neural lineages in …
[HTML][HTML] Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature
T Bosman, C Simonin, D Launay, S Caron… - Rheumatology …, 2008 - Springer
Idiopathic hypertrophic cranial pachymeningitis (IHCP) is a rare clinical entity, characterized
by a chronic inflammation causing thickening of the dura. Adequate therapeutic …
by a chronic inflammation causing thickening of the dura. Adequate therapeutic …
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
…, K Seppi, B Shannon, D Shprecher, C Simonin… - The Lancet …, 2019 - thelancet.com
Background Previous trials have shown that pridopidine might reduce motor impairment in
patients with Huntington's disease. The aim of this study was to ascertain whether higher …
patients with Huntington's disease. The aim of this study was to ascertain whether higher …
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease
CM Dhaenens, S Burnouf, C Simonin… - Neurobiology of …, 2009 - Elsevier
Based on the pathophysiological role of adenosine A2A receptors in HD, we have evaluated
the association of the 1976C/T single-nucleotide polymorphism in the ADORA2A gene …
the association of the 1976C/T single-nucleotide polymorphism in the ADORA2A gene …
Association between caffeine intake and age at onset in Huntington's disease
C Simonin, C Duru, J Salleron, P Hincker… - Neurobiology of …, 2013 - Elsevier
Habitual consumption of caffeine, a non-selective adenosine receptor (AR) antagonist, has
been suggested to be beneficial in Parkinson's and Alzheimer's diseases. Experimental …
been suggested to be beneficial in Parkinson's and Alzheimer's diseases. Experimental …
Low molecular weight heparin-loaded polymeric nanoparticles: formulation, characterization, and release characteristics
V Hoffart, N Ubrich, C Simonin, V Babak… - Drug development …, 2002 - Taylor & Francis
The aim of the present work was to investigate the preparation of low molecular weight
heparin (LMWH) nanoparticles (NP) as potential oral heparin carriers. The NP were …
heparin (LMWH) nanoparticles (NP) as potential oral heparin carriers. The NP were …
Identification of potent and selective small molecule inhibitors of the cation channel TRPM4
…, D Ross‐Kaschitza, C Simonin… - British journal of …, 2018 - Wiley Online Library
Background and Purpose TRPM4 is a calcium‐activated non‐selective cation channel
expressed in many tissues and implicated in several diseases, and has not yet been …
expressed in many tissues and implicated in several diseases, and has not yet been …
Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations
…, A Destée, L Defebvre, C Moreau, C Simonin… - Parkinsonism & Related …, 2020 - Elsevier
Background Subthalamic nucleus deep brain stimulation (STN-DBS) has demonstrated its
efficacy on motor complications in advanced Parkinson's disease (PD) but does not modify …
efficacy on motor complications in advanced Parkinson's disease (PD) but does not modify …
Embryonic stem cells: meeting the needs for cell therapy
MT Mitjavila-Garcia, C Simonin… - Advanced drug delivery …, 2005 - Elsevier
Cell therapy in diverse organs has bloomed for degenerative diseases over the past
decade, following a previous period of development in which haematopoietic stem cells …
decade, following a previous period of development in which haematopoietic stem cells …
Optimization of TRPV6 calcium channel inhibitors using a 3D ligand‐based virtual screening method
Herein, we report the discovery of the first potent and selective inhibitor of TRPV6, a calcium
channel overexpressed in breast and prostate cancer, and its use to test the effect of …
channel overexpressed in breast and prostate cancer, and its use to test the effect of …